scispace - formally typeset
P

Paula Peleteiro

Researcher at University of Santiago de Compostela

Publications -  14
Citations -  484

Paula Peleteiro is an academic researcher from University of Santiago de Compostela. The author has contributed to research in topics: Prostate cancer & Genome-wide association study. The author has an hindex of 8, co-authored 13 publications receiving 366 citations.

Papers
More filters
Journal ArticleDOI

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

Tokhir Dadaev, +339 more
TL;DR: The authors perform multivariate fine-mapping of known PrCa GWAS loci, identifying variants enriched for biological function, explaining more familial relative risk, and with potential application in clinical risk profiling.
Journal ArticleDOI

Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy

TL;DR: This study increases the understanding of the architecture of common genetic variants affecting radiotoxicity, points to novel radio-pathogenic mechanisms, and develops risk models for testing in clinical studies.
Journal ArticleDOI

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.

TL;DR: The results show that heterogeneous radiotherapy cohorts can be combined to identify new moderate-penetrance genetic variants associated with radiotherapy toxicity, and provides a basis for larger collaborative efforts to identify enough variants for a future test involving polygenic risk profiling.
Journal ArticleDOI

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, +147 more
TL;DR: The comprehensive centralised database and linked biobank is a valuable resource for the radiotherapy community for validating predictive models and biomarkers and will also enable a better understanding of how many people suffer with radiotherapy toxicity.